Predictive factors for methicillin-resistant Staphylococcus aureus (MRSA) infection in a MRSA screening protocol.

D. Reis (Porto, Portugal), M. Costa Silva (Porto, Portugal), C. Ribeiro (Porto, Portugal), E. Silva (Porto, Portugal), M. Dias (Porto, Portugal), D. Pires Coutinho (Porto, Portugal), T. Shiang (Porto, Portugal), G. Abreu (Porto, Portugal), I. Sanches (Porto, Portugal), M. Vanzeller (Porto, Portugal)

Source: International Congress 2018 – Difficult-to-treat respiratory infections
Session: Difficult-to-treat respiratory infections
Session type: Thematic Poster
Number: 4716
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Reis (Porto, Portugal), M. Costa Silva (Porto, Portugal), C. Ribeiro (Porto, Portugal), E. Silva (Porto, Portugal), M. Dias (Porto, Portugal), D. Pires Coutinho (Porto, Portugal), T. Shiang (Porto, Portugal), G. Abreu (Porto, Portugal), I. Sanches (Porto, Portugal), M. Vanzeller (Porto, Portugal). Predictive factors for methicillin-resistant Staphylococcus aureus (MRSA) infection in a MRSA screening protocol.. 4716

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Community-associated methicillin-resistant staphylococcus aureus (CA-MRSA) as a cause of hospital-acquired pneumonia (HAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 410s
Year: 2007

Clinical outcomes of patients with hospital-acquired pneumonia due to community-associated methicillin resistant staphylococcus aureus (CA-MRSA)
Source: Eur Respir J 2007; 30: Suppl. 51, 407s
Year: 2007

Methicillin-resistant Staphylococcus aureus (MRSA) active screening in a Pulmonology department.
Source: International Congress 2018 – Clinical challenges in respiratory infection
Year: 2018


What is MRSA?
Source: Eur Respir J 2009; 34: 1190-1196
Year: 2009



Risk factors for methicillin-resistant Staphylococcus aureus isolation from serially obtained sputum in patients hospitalized with pneumonia
Source: Virtual Congress 2020 – Clinical challenges in pneumonia
Year: 2020


Vancomycin MICs for respiratory isolates of community-associated MRSA and hospital-associated MRSA
Source: Annual Congress 2007 - Pulmonary infections in the immunocompetent and immunocompromised host
Year: 2007


Treatment challenges in methicillin resistant Staphylococcus aureus infections
Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen?
Year: 2006


Mechanisms of acquisition of resistance in Staphylococcus aureus
Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen?
Year: 2006


Staphlococcus aureus: susceptibility to antibacterial drugs and rate of MRSA
Source: Eur Respir J 2006; 28: Suppl. 50, 788s
Year: 2006

The efficacies of macrolides in a murine model of methicillin-resistant staphylococcus aureus hematogenous pulmonary infection
Source: Eur Respir J 2002; 20: Suppl. 38, 357s
Year: 2002

Prevalence and impact on FEV1 decline of methicillin-resistant Staphylococcus aureus infection in patients with cystic fibrosis
Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge
Year: 2011


Molecular epidemiology and antimicrobial resistance of methicillin-resistant staphylococcus aureus isolated from nasal swab at intensive care unit
Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens
Year: 2008


Diagnostic challenge in community-acquired pneumonia and hospital-acquired pneumonia: risk factors and diagnostic methods for methicillin resistant Staphylococcus aureus
Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen?
Year: 2006


Significance of methicillin-resistant staphylococcus aureus in lower respiratory tract infections
Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens
Year: 2008

An experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated piglets
Source: Eur Respir J 2010; 36: 901-906
Year: 2010



Detection of alpha-hemolysin in Staphylococcus aureus derived respiratory strains: correlation with microbiological and clinical variables
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017

Prevention of MRSA pneumonia by oral vancomycin decontamination: a randomised trial
Source: Eur Respir J 2004; 23: 921-926
Year: 2004



Community-acquired pneumonia due to S. aureus
Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia
Year: 2011

Retrospective case review of methicillin-resistant staphylococcus aureus (MRSA) infection in a paediatric shared-care cystic fibrosis clinic
Source: Eur Respir J 2007; 30: Suppl. 51, 647s
Year: 2007